These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16802838)
1. NICE says no to inhaled insulin: what lessons should we learn? Freemantle N Pharmacoeconomics; 2006; 24(7):627-9. PubMed ID: 16802838 [No Abstract] [Full Text] [Related]
2. Inhaled insulin: gone with the wind? Mathieu C; Gale EA Diabetologia; 2008 Jan; 51(1):1-5. PubMed ID: 18026925 [No Abstract] [Full Text] [Related]
4. [Treatment of patients with diabetes mellitus by means of inhaled insulin]. Simsek S; de Galan BE; Tack CJ; Heine RJ Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511 [TBL] [Abstract][Full Text] [Related]
9. Inhaled insulin (exubera). Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019 [No Abstract] [Full Text] [Related]
10. Inhaled human insulin. Owens DR; Grimley J; Kirkpatrick P Nat Rev Drug Discov; 2006 May; 5(5):371-2. PubMed ID: 16802444 [No Abstract] [Full Text] [Related]
11. Willingness to pay for inhaled insulin: a contingent valuation approach. Sadri H; MacKeigan LD; Leiter LA; Einarson TR Pharmacoeconomics; 2005; 23(12):1215-27. PubMed ID: 16336016 [TBL] [Abstract][Full Text] [Related]
12. Inhaled insulin: the solution for suboptimal diabetes control? Amiel SA Clin Med (Lond); 2007 Oct; 7(5):430-2. PubMed ID: 17990701 [No Abstract] [Full Text] [Related]
13. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus. Dunn C; Curran MP Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022 [TBL] [Abstract][Full Text] [Related]
14. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Pham DQ; Cohen H; Chu V J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117 [TBL] [Abstract][Full Text] [Related]
15. [Inhaled human insulin (Exubera): a revolution?]. Daubresse JC; Sternon J Rev Med Brux; 2006; 27(6):493-7. PubMed ID: 17256415 [TBL] [Abstract][Full Text] [Related]
17. Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials. Hollander PA; Krasner A; Klioze S; Schwartz P; Duggan W Diabetes Care; 2007 Oct; 30(10):2508-10. PubMed ID: 17536080 [No Abstract] [Full Text] [Related]
18. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258 [TBL] [Abstract][Full Text] [Related]
19. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al. Kanna B; Abreu-Pacheco H Diabetes Care; 2007 Feb; 30(2):445-6; author reply 446. PubMed ID: 17259531 [No Abstract] [Full Text] [Related]
20. Years in the making: inhaled insulin has finally arrived. Strain J S D Med; 2006 Jul; 59(7):301-2. PubMed ID: 16895053 [No Abstract] [Full Text] [Related] [Next] [New Search]